{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:42:08Z","timestamp":1793770928662,"version":"4.6.1"},"reference-count":248,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370378"],"award-info":[{"award-number":["82370378"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tsqn202211310"],"award-info":[{"award-number":["tsqn202211310"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07088-9","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:32:55Z","timestamp":1761042775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Emerging therapy strategies for energy metabolism in acute myocardial infarction"],"prefix":"10.1186","volume":"23","author":[{"given":"Ruixin","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dazhou","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuguo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1224-0509","authenticated-orcid":false,"given":"Chuanbao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"7088_CR1","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1093\/eurheartj\/ehaa035","volume":"41","author":"TS Hartikainen","year":"2020","unstructured":"Hartikainen TS, Soerensen NA, Haller PM, Gossling A, Lehmacher J, Zeller T, et al. Clinical application of the 4th Universal Definition of Myocardial Infarction. Eur Hear J. 2020;41:2209.","journal-title":"Eur Hear J"},{"key":"7088_CR2","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019 update from the GBD 2019 study. J Am Coll Cardiol. 2020;76:2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"key":"7088_CR3","doi-asserted-by":"publisher","first-page":"E577","DOI":"10.1152\/ajpendo.00014.2017","volume":"313","author":"TT Li","year":"2017","unstructured":"Li TT, Xu J, Qin XH, Hou ZX, Guo YZ, Liu ZH, et al. Glucose oxidation positively regulates glucose uptake and improves cardiac function recovery after myocardial reperfusion. Am J Physiol-Endocrinol MetabIsm. 2017;313:E577\u201385.","journal-title":"Am J Physiol-Endocrinol MetabIsm"},{"key":"7088_CR4","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1001\/jama.297.17.1892","volume":"297","author":"KAA Fox","year":"2007","unstructured":"Fox KAA, Steg PG, Eagle KA, Goodman SG, Anderson FA Jr, Granger CB, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999\u20132006. Jama-J Am Med Assoc. 2007;297:1892\u2013900.","journal-title":"Jama-J Am Med Assoc"},{"key":"7088_CR5","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1093\/eurheartj\/ehl196","volume":"27","author":"L Mandelzweig","year":"2006","unstructured":"Mandelzweig L, Battler A, Boyko V, Bueno H, Danchin N, Filippatos G, et al. The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J. 2006;27:2285\u201393.","journal-title":"Eur Heart J"},{"key":"7088_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.119.008494","author":"F Latif","year":"2020","unstructured":"Latif F, Uyeda L, Edson R, Bhatt DL, Goldman S, Holmes DR Jr, et al. Stent-only versus adjunctive balloon angioplasty approach for Saphenous Vein Graft Percutaneous Coronary Intervention insights from DIVA trial. Circ Cardiovasc Interv. 2020. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.119.008494.","journal-title":"Circ Cardiovasc Interv"},{"key":"7088_CR7","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1161\/01.CIR.0000016602.96363.36","volume":"105","author":"S Verma","year":"2002","unstructured":"Verma S, Fedak PWM, Weisel RD, Butany J, Rao V, Maitlund A, et al. Fundamentals of reperfusion injury for the clinical cardiologist. Circulation. 2002;105:2332\u20136.","journal-title":"Circulation"},{"key":"7088_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1172\/JCI62874","volume":"123","author":"DJ Hausenloy","year":"2013","unstructured":"Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013;123:92\u2013100.","journal-title":"J Clin Invest"},{"key":"7088_CR9","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1093\/eurheartj\/eht090","volume":"34","author":"GM Fr\u00f6hlich","year":"2013","unstructured":"Fr\u00f6hlich GM, Meier P, White SK, Yellon DM, Hausenloy DJ. Myocardial reperfusion injury: looking beyond primary PCI. Eur Heart J. 2013;34:1714.","journal-title":"Eur Heart J"},{"key":"7088_CR10","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1161\/01.RES.86.5.580","volume":"86","author":"PF Kantor","year":"2000","unstructured":"Kantor PF, Lucien A, Kozak R, Lopaschuk GD. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res. 2000;86:580\u20138.","journal-title":"Circ Res"},{"key":"7088_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1152\/physrev.00015.2009","volume":"90","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk GD, Ussher JR, Folmes CDL, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010;90:207\u201358.","journal-title":"Physiol Rev"},{"key":"7088_CR12","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1056\/NEJMra063052","volume":"356","author":"S Neubauer","year":"2007","unstructured":"Neubauer S. Mechanisms of disease - The failing heart - An engine out of fuel. N Engl J Med. 2007;356:1140\u201351.","journal-title":"N Engl J Med"},{"key":"7088_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1161\/CIRCRESAHA.113.302095","volume":"113","author":"SC Kolwicz Jr","year":"2013","unstructured":"Kolwicz SC Jr, Purohit S, Tian R. Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes. Circ Res. 2013;113:603\u201316.","journal-title":"Circ Res"},{"key":"7088_CR14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/cvr\/cvv105","volume":"106","author":"D Abdurrachim","year":"2015","unstructured":"Abdurrachim D, Luiken JJFP, Nicolay K, Glatz JFC, Prompers JJ, Nabben M. Good and bad consequences of altered fatty acid metabolism in heart failure: evidence from mouse models. Cardiovasc Res. 2015;106:194\u2013205.","journal-title":"Cardiovasc Res"},{"key":"7088_CR15","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","volume":"1","author":"PJ Randle","year":"1963","unstructured":"Randle PJ, Garland PB, Newsholme EA, Hales CN. Glucose fatty-acid cycle - its role in insulin sensitivity and metabolic disturbances of diabetes mellitus. Lancet. 1963;1:785.","journal-title":"Lancet"},{"key":"7088_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2018.00068","author":"QG Karwi","year":"2018","unstructured":"Karwi QG, Uddin GM, Ho KL, Lopaschuk GD. Loss of metabolic flexibility in the failing heart. Front Cardiovasc Med. 2018. https:\/\/doi.org\/10.3389\/fcvm.2018.00068.","journal-title":"Front Cardiovasc Med"},{"key":"7088_CR17","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk GD, Karwi QG, Tian R, Wende AR, Abel ED. Cardiac energy metabolism in heart failure. Circ Res. 2021;128:1487\u2013513.","journal-title":"Circ Res"},{"key":"7088_CR18","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1093\/cvr\/cvz045","volume":"115","author":"KL Ho","year":"2019","unstructured":"Ho KL, Zhang L, Wagg C, Al Batran R, Gopal K, Levasseur J, et al. Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency. Cardiovasc Res. 2019;115:1606\u201316.","journal-title":"Cardiovasc Res"},{"key":"7088_CR19","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.2165\/00007256-200737120-00005","volume":"37","author":"JL Bowtell","year":"2007","unstructured":"Bowtell JL, Marwood S, Bruce M, Constantin-Teodosiu D, Greenhaff PL. Tricarboxylic acid cycle intermediate pool size - Functional importance for oxidative metabolism in exercising human skeletal muscle. Sports Med. 2007;37:1071\u201388.","journal-title":"Sports Med"},{"key":"7088_CR20","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/cvr\/cvr051","volume":"91","author":"TT Nielsen","year":"2011","unstructured":"Nielsen TT, Stottrup NB, Lofgren B, Botker HE. Metabolic fingerprint of ischaemic cardioprotection: importance of the malate-aspartate shuttle. Cardiovasc Res. 2011;91:382\u201391.","journal-title":"Cardiovasc Res"},{"key":"7088_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nature19794","volume":"538","author":"K Fiedorczuk","year":"2016","unstructured":"Fiedorczuk K, Letts JA, Degliesposti G, Kaszuba K, Skehel M, Sazanov LA. Atomic structure of the entire mammalian mitochondrial complex I. Nature. 2016;538:406.","journal-title":"Nature"},{"key":"7088_CR22","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1056\/NEJMra022567","volume":"348","author":"S DiMauro","year":"2003","unstructured":"DiMauro S, Schon EA. Mechanisms of disease: mitochondrial respiratory-chain diseases. N Engl J Med. 2003;348:2656\u201368.","journal-title":"N Engl J Med"},{"key":"7088_CR23","doi-asserted-by":"publisher","first-page":"C69","DOI":"10.1152\/ajpcell.00455.2021","volume":"323","author":"S Chenna","year":"2022","unstructured":"Chenna S, Koopman WJH, Prehn JHM, Connolly NMC. Mechanisms and mathematical modeling of ROS production by the mitochondrial electron transport chain. Am J Physiol-Cell Physiol. 2022;323:C69\u201383.","journal-title":"Am J Physiol-Cell Physiol"},{"key":"7088_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101630","author":"NI Markevich","year":"2020","unstructured":"Markevich NI, Galimova MH, Markevich LN. Hysteresis and bistability in the succinate-CoQ reductase activity and reactive oxygen species production in the mitochondrial respiratory complex II. Redox Biol. 2020. https:\/\/doi.org\/10.1016\/j.redox.2020.101630.","journal-title":"Redox Biol"},{"key":"7088_CR25","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nature19359","volume":"537","author":"J Gu","year":"2016","unstructured":"Gu J, Wu M, Guo R, Yan K, Lei J, Gao N, et al. The architecture of the mammalian respirasome. Nature. 2016;537:639.","journal-title":"Nature"},{"key":"7088_CR26","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nature20157","volume":"539","author":"S Cogliati","year":"2016","unstructured":"Cogliati S, Calvo E, Loureiro M, Guaras AM, Nieto-Arellano R, Garcia-Poyatos C, et al. Mechanism of super-assembly of respiratory complexes III and IV. Nature. 2016;539:579.","journal-title":"Nature"},{"key":"7088_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101674","author":"D Nolfi-Donegan","year":"2020","unstructured":"Nolfi-Donegan D, Braganza A, Shiva S. Mitochondrial electron transport chain: oxidative phosphorylation, oxidant production, and methods of measurement. Redox Biol. 2020. https:\/\/doi.org\/10.1016\/j.redox.2020.101674.","journal-title":"Redox Biol"},{"key":"7088_CR28","doi-asserted-by":"publisher","first-page":"S243","DOI":"10.33549\/physiolres.935407","volume":"73","author":"K Tauchmannova","year":"2024","unstructured":"Tauchmannova K, Pecinova A, Houstek J, Mracek T. Variability of clinical phenotypes caused by isolated defects of mitochondrial ATP synthase. Physiol Res. 2024;73:S243\u201378.","journal-title":"Physiol Res"},{"key":"7088_CR29","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1073\/pnas.0408962102","volume":"102","author":"RG Weiss","year":"2005","unstructured":"Weiss RG, Gerstenblith G, Bottomley PA. ATP flux through creatine kinase in the normal, stressed, and failing human heart. Proc Natl Acad Sci USA. 2005;102:808\u201313.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7088_CR30","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.1111\/jcmm.15180","volume":"24","author":"CJ Zuurbier","year":"2020","unstructured":"Zuurbier CJ, Bertrand L, Beauloye CR, Andreadou I, Ruiz-Meana M, Jespersen NR, et al. Cardiac metabolism as a driver and therapeutic target of myocardial infarction. J Cell Mol Med. 2020;24:5937\u201354.","journal-title":"J Cell Mol Med"},{"key":"7088_CR31","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.71270","author":"RT Lindsay","year":"2021","unstructured":"Lindsay RT, Dieckmann S, Krzyzanska D, Manetta-Jones D, West JA, Castro C, et al. \u0392-hydroxybutyrate accumulates in the rat heart during low-flow ischaemia with implications for functional recovery. Elife. 2021. https:\/\/doi.org\/10.7554\/eLife.71270.","journal-title":"Elife"},{"key":"7088_CR32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0008-6363(98)00100-X","volume":"39","author":"LM King","year":"1998","unstructured":"King LM, Opie LH. Glucose delivery is a major determinant of glucose utilisation in the ischemic myocardium with a residual coronary flow. Cardiovasc Res. 1998;39:381\u201392.","journal-title":"Cardiovasc Res"},{"key":"7088_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1023\/A:1006870419309","volume":"180","author":"LM King","year":"1998","unstructured":"King LM, Opie LH. Glucose and glycogen utilisation in myocardial ischemia - changes in metabolism and consequences for the myocyte. Mol Cell Biochem. 1998;180:3\u201326.","journal-title":"Mol Cell Biochem"},{"key":"7088_CR34","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1161\/01.RES.79.5.940","volume":"79","author":"B Liu","year":"1996","unstructured":"Liu B, Clanachan AS, Schulz R, Lopaschuk GD. Cardiac efficiency is improved after ischemia by altering both the source and fate of protons. Circ Res. 1996;79:940\u20138.","journal-title":"Circ Res"},{"key":"7088_CR35","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/0022-2828(91)91642-5","volume":"23","author":"SC Dennis","year":"1991","unstructured":"Dennis SC, Gevers W, Opie LH. Protons in ischemia - where do they come from - where do they go to. J Mol Cell Cardiol. 1991;23:1077\u201386.","journal-title":"J Mol Cell Cardiol"},{"key":"7088_CR36","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007546","author":"M Kohlhauer","year":"2018","unstructured":"Kohlhauer M, Dawkins S, Costa ASH, Lee R, Young T, Pell VR, et al. Metabolomic profiling in acute ST-segment-elevation myocardial infarction identifies succinate as an early marker of human ischemia-reperfusion injury. J Am Heart Assoc. 2018. https:\/\/doi.org\/10.1161\/JAHA.117.007546.","journal-title":"J Am Heart Assoc"},{"key":"7088_CR37","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature13909","volume":"515","author":"ET Chouchani","year":"2014","unstructured":"Chouchani ET, Pell VR, Gaude E, Aksentijevic D, Sundier SY, Robb EL, et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014;515:431.","journal-title":"Nature"},{"key":"7088_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165768","author":"H Bugger","year":"2020","unstructured":"Bugger H, Pfeil K. Mitochondrial ROS in myocardial ischemia reperfusion and remodeling. Biochim Biophys Acta (BBA). 2020. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165768.","journal-title":"Biochim Biophys Acta (BBA)"},{"key":"7088_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12035-012-8344-z","volume":"47","author":"TH Sanderson","year":"2013","unstructured":"Sanderson TH, Reynolds CA, Kumar R, Przyklenk K, H\u00fcttemann M. Molecular mechanisms of ischemia-reperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive oxygen species generation. Mol Neurobiol. 2013;47:9\u201323.","journal-title":"Mol Neurobiol"},{"key":"7088_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1161\/01.RES.0000109416.56608.64","volume":"94","author":"G Paradies","year":"2004","unstructured":"Paradies G, Petrosillo G, Pistolese M, Di Venosa N, Federici A, Ruggiero FM. Decrease in mitochondrial complex i activity in ischemic\/reperfused rat heart - involvement of reactive oxygen species and cardiolipin. Circ Res. 2004;94:53\u20139.","journal-title":"Circ Res"},{"key":"7088_CR41","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.bbabio.2018.05.019","volume":"1859","author":"S Cadenas","year":"2018","unstructured":"Cadenas S. Mitochondrial uncoupling, ROS generation and cardioprotection. Biochim Biophys Acta-Bioenerg. 2018;1859:940\u201350.","journal-title":"Biochim Biophys Acta-Bioenerg"},{"key":"7088_CR42","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.pharmthera.2011.11.004","volume":"133","author":"K Raedschelders","year":"2012","unstructured":"Raedschelders K, Ansley DM, Chen DDY. The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion. Pharmacol Ther. 2012;133:230\u201355.","journal-title":"Pharmacol Ther"},{"key":"7088_CR43","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","volume":"365","author":"RH Eckel","year":"2005","unstructured":"Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415\u201328.","journal-title":"Lancet"},{"key":"7088_CR44","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1124\/pr.113.008300","volume":"66","author":"P Ferdinandy","year":"2014","unstructured":"Ferdinandy P, Hausenloy DJ, Heusch G, Baxter GF, Schulz R. Interaction of risk factors, comorbidities, and comedications with ischemia\/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Pharmacol Rev. 2014;66:1142\u201374.","journal-title":"Pharmacol Rev"},{"key":"7088_CR45","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1007\/s00125-007-0735-8","volume":"50","author":"DM Ouwens","year":"2007","unstructured":"Ouwens DM, Diamant M, Fodor M, Habets DDJ, Pelsers MMAL, El Hasnaoui M, et al. Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification. Diabetologia. 2007;50:1938\u201348.","journal-title":"Diabetologia"},{"key":"7088_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60387-7","author":"M Karimi","year":"2020","unstructured":"Karimi M, Petkova V, Asara JM, Griffin MJ, Sellke FW, Bishop AR, et al. Metabolomics and the pig model reveal aberrant cardiac energy metabolism in metabolic syndrome. Sci Rep. 2020. https:\/\/doi.org\/10.1038\/s41598-020-60387-7.","journal-title":"Sci Rep"},{"key":"7088_CR47","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jacc.2017.05.043","volume":"70","author":"B Niemann","year":"2017","unstructured":"Niemann B, Rohrbach S, Miller MR, Newby DE, Fuster V, Kovacic JC. Oxidative stress and cardiovascular risk: obesity, diabetes, smoking, and pollution part 3 of a 3-part series. J Am Coll Cardiol. 2017;70:230\u201351.","journal-title":"J Am Coll Cardiol"},{"key":"7088_CR48","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1152\/physiol.00008.2006","volume":"21","author":"S Boudina","year":"2006","unstructured":"Boudina S, Abel ED. Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes. Physiology. 2006;21:250\u20138.","journal-title":"Physiology"},{"key":"7088_CR49","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S0891-5849(99)00032-5","volume":"27","author":"G Paradies","year":"1999","unstructured":"Paradies G, Petrosillo G, Pistolese M, Di Venosa N, Serena D, Ruggiero FM. Lipid peroxidation and alterations to oxidative metabolism in mitochondria isolated from rat heart subjected to ischemia and reperfusion. Free Radic Biol Med. 1999;27:42\u201350.","journal-title":"Free Radic Biol Med"},{"key":"7088_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097898","author":"SK Masenga","year":"2023","unstructured":"Masenga SK, Kabwe LS, Chakulya M, Kirabo A. Mechanisms of oxidative stress in metabolic syndrome. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24097898.","journal-title":"Int J Mol Sci"},{"key":"7088_CR51","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1089\/ars.2006.8.1865","volume":"8","author":"DP Jones","year":"2006","unstructured":"Jones DP. Redefining oxidative stress. Antioxid Redox Signal. 2006;8:1865\u201379.","journal-title":"Antioxid Redox Signal"},{"key":"7088_CR52","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1096\/fj.02-0729fje","volume":"17","author":"G Petrosillo","year":"2003","unstructured":"Petrosillo G, Ruggiero FM, Di Venosa N, Paradies G. Decreased complex III activity in mitochondria isolated from rat heart subjected to ischemia and reperfusion: role of reactive oxygen species and cardiolipin. Faseb J. 2003;17:714.","journal-title":"Faseb J"},{"key":"7088_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.313","author":"X Zhu","year":"2013","unstructured":"Zhu X, Zuo L. Characterization of oxygen radical formation mechanism at early cardiac ischemia. Cell Death Dis. 2013. https:\/\/doi.org\/10.1038\/cddis.2013.313.","journal-title":"Cell Death Dis"},{"key":"7088_CR54","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev-pharmtox-010715-103335","volume":"57","author":"EJ Lesnefsky","year":"2017","unstructured":"Lesnefsky EJ, Chen Q, Tandler B, Hoppel CL, Insel PA. Mitochondrial dysfunction and myocardial ischemia-reperfusion: implications for novel therapies. Annu Rev Pharmacol Toxicol. 2017;57:535\u201365.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"7088_CR55","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.dnarep.2010.09.008","volume":"10","author":"DB Rhee","year":"2011","unstructured":"Rhee DB, Ghosh A, Lu J, Bohr VA, Liu Y. Factors that influence telomeric oxidative base damage and repair by DNA glycosylase OGG1. DNA Repair. 2011;10:34\u201344.","journal-title":"DNA Repair"},{"key":"7088_CR56","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S1097-2765(02)00520-8","volume":"9","author":"O Vafa","year":"2002","unstructured":"Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM, et al. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell. 2002;9:1031\u201344.","journal-title":"Mol Cell"},{"key":"7088_CR57","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1089\/ars.2023.0252","volume":"41","author":"C Chahla","year":"2024","unstructured":"Chahla C, Kovacic H, Ferhat L, Leloup L. Pathological impact of redox post-translational modifications. Antioxid Redox Signal. 2024;41:152\u201380.","journal-title":"Antioxid Redox Signal"},{"key":"7088_CR58","doi-asserted-by":"publisher","first-page":"44784","DOI":"10.1074\/jbc.M207217200","volume":"277","author":"J St-Pierre","year":"2002","unstructured":"St-Pierre J, Buckingham JA, Roebuck SJ, Brand MD. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem. 2002;277:44784\u201390.","journal-title":"J Biol Chem"},{"key":"7088_CR59","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0047-6374(97)00076-6","volume":"98","author":"A Herrero","year":"1997","unstructured":"Herrero A, Barja G. Sites and mechanisms responsible for the low rate of free radical production of heart mitochondria in the long-lived pigeon. Mech Ageing Dev. 1997;98:95\u2013111.","journal-title":"Mech Ageing Dev"},{"key":"7088_CR60","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/ars.2011.4373","volume":"18","author":"C Villeneuve","year":"2013","unstructured":"Villeneuve C, Guilbeau-Frugier C, Sicard P, Lairez O, Ordener C, Duparc T, et al. P53-PGC-1\u03b1 pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by monoamine oxidase-A upregulation: role in chronic left ventricular dysfunction in mice. Antioxid Redox Signal. 2013;18:5\u201318.","journal-title":"Antioxid Redox Signal"},{"key":"7088_CR61","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41569-019-0260-8","volume":"17","author":"YX Zhang","year":"2020","unstructured":"Zhang YX, Murugesan P, Huang K, Cai H. NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets. Nat Rev Cardiol. 2020;17:170\u201394.","journal-title":"Nat Rev Cardiol"},{"key":"7088_CR62","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.cell.2005.05.011","volume":"122","author":"M Giorgio","year":"2005","unstructured":"Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, et al. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell. 2005;122:221\u201333.","journal-title":"Cell"},{"key":"7088_CR63","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.abb.2003.07.004","volume":"420","author":"RA Gottlieb","year":"2003","unstructured":"Gottlieb RA. Cytochrome P450: major player in reperfusion injury. Arch Biochem Biophys. 2003;420:262\u20137.","journal-title":"Arch Biochem Biophys"},{"key":"7088_CR64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0009-8981(03)00003-2","volume":"329","author":"I Dalle-Donne","year":"2003","unstructured":"Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta. 2003;329:23\u201338.","journal-title":"Clin Chim Acta"},{"key":"7088_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-023-00781-3","author":"D Talwar","year":"2023","unstructured":"Talwar D, Miller CG, Grossmann J, Szyrwiel L, Schwecke T, Demichev V, et al. The GAPDH redox switch safeguards reductive capacity and enables survival of stressed tumour cells. Nat Metab. 2023. https:\/\/doi.org\/10.1038\/s42255-023-00781-3.","journal-title":"Nat Metab"},{"key":"7088_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102202","author":"KS Chun","year":"2020","unstructured":"Chun KS, Jang JH, Kim DH. Perspectives regarding the intersections between STAT3 and oxidative metabolism in cancer. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9102202.","journal-title":"Cells"},{"key":"7088_CR67","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3892\/ijo.2013.1843","volume":"42","author":"BJ Tan","year":"2013","unstructured":"Tan BJ, Chiu GNC. Role of oxidative stress, endoplasmic reticulum stress and ERK activation in triptolide-induced apoptosis. Int J Oncol. 2013;42:1605\u201312.","journal-title":"Int J Oncol"},{"key":"7088_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179255","author":"S Iliadis","year":"2024","unstructured":"Iliadis S, Papanikolaou NA. Reactive oxygen species mechanisms that regulate protein-protein interactions in cancer. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25179255.","journal-title":"Int J Mol Sci"},{"key":"7088_CR69","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","volume":"113","author":"WS Yang","year":"2016","unstructured":"Yang WS, Kim KJ, Gaschler MM, Patel M, Shchepinov MS, Stockwell BR. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci U S A. 2016;113:E4966\u201375.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7088_CR70","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0005-2760(80)90209-X","volume":"620","author":"A Benedetti","year":"1980","unstructured":"Benedetti A, Comporti M, Esterbauer H. Identification of 4-hydroxynoneal as a cyto-toxic product originating from the peroxidation of liver microsomal lipids. Biochim Biophys Acta (BBA). 1980;620:281\u201396.","journal-title":"Biochim Biophys Acta (BBA)"},{"key":"7088_CR71","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1042\/bj2080129","volume":"208","author":"H Esterbauer","year":"1982","unstructured":"Esterbauer H, Cheeseman KH, Dianzani MU, Poli G, Slater TF. Separation and characterization of the aldehydic products of lipid-peroxidation stimulated by ADP-Fe2+ in rat-liver microsomes. Biochem J. 1982;208:129\u201340.","journal-title":"Biochem J"},{"key":"7088_CR72","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10337-012-2237-1","volume":"75","author":"M Giera","year":"2012","unstructured":"Giera M, Lingeman H, Niessen WMA. Recent advancements in the LC- and GC-based analysis of malondialdehyde (MDA): a brief overview. Chromatographia. 2012;75:433\u201340.","journal-title":"Chromatographia"},{"key":"7088_CR73","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/sj.bjp.0705384","volume":"139","author":"DV Folden","year":"2003","unstructured":"Folden DV, Gupta A, Sharma AC, Li SY, Saari JT, Ren J. Malondialdehyde inhibits cardiac contractile function in ventricular myocytes via a p38 mitogen-activated protein kinase-dependent mechanism. Br J Pharmacol. 2003;139:1310\u20136.","journal-title":"Br J Pharmacol"},{"key":"7088_CR74","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0165-1110(90)90014-3","volume":"238","author":"H Esterbauer","year":"1990","unstructured":"Esterbauer H, Eckl P, Ortner A. Possible mutagens derived from lipids and lipid precursors. Mutat Res. 1990;238:223\u201333.","journal-title":"Mutat Res"},{"key":"7088_CR75","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/cbf.290110409","volume":"11","author":"N Zarkovic","year":"1993","unstructured":"Zarkovic N, Ilic Z, Jurin M, Schaur RJ, Puhl H, Esterbauer H. Stimulation of HeLa-cell growth by physiological concentrations of 4-hydroxynonenal. Cell Biochem Funct. 1993;11:279\u201386.","journal-title":"Cell Biochem Funct"},{"key":"7088_CR76","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/10715762.2013.864761","volume":"48","author":"VR Mali","year":"2014","unstructured":"Mali VR, Palaniyandi SS. Regulation and therapeutic strategies of 4-hydroxy-2-nonenal metabolism in heart disease. Free Radic Res. 2014;48:251\u201363.","journal-title":"Free Radic Res"},{"key":"7088_CR77","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1134\/S0006297910090014","volume":"75","author":"EE Dubinina","year":"2010","unstructured":"Dubinina EE, Dadali VA. Role of 4-hydroxy-trans-2-nonenal in cell functions. Biochemistry-Moscow. 2010;75:1069\u201387.","journal-title":"Biochemistry-Moscow"},{"key":"7088_CR78","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.redox.2014.12.011","volume":"4","author":"HQ Zhong","year":"2015","unstructured":"Zhong HQ, Yin HY. Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: focusing on mitochondria. Redox Biol. 2015;4:193\u20139.","journal-title":"Redox Biol"},{"key":"7088_CR79","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1080\/15548627.2017.1356948","volume":"13","author":"M Dodson","year":"2017","unstructured":"Dodson M, Wani WY, Redmann M, Benavides GA, Johnson MS, Ouyang X, et al. Regulation of autophagy, mitochondrial dynamics, and cellular bioenergetics by 4-hydroxynonenal in primary neurons. Autophagy. 2017;13:1828\u201340.","journal-title":"Autophagy"},{"key":"7088_CR80","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s11596-019-2057-8","volume":"39","author":"LL Yang","year":"2019","unstructured":"Yang LL, Chen H, Wang J, Xia T, Sun H, Yuan CH, et al. 4-HNE induces apoptosis of human retinal pigment epithelial cells by modifying HSP70. Curr Med Sci. 2019;39:442\u20138.","journal-title":"Curr Med Sci"},{"key":"7088_CR81","doi-asserted-by":"publisher","first-page":"721795","DOI":"10.3389\/fcell.2021.721795","volume":"9","author":"XX Zhai","year":"2021","unstructured":"Zhai XX, Wang WJ, Sun SK, Han Y, Li JX, Cao SC, et al. 4-hydroxy-2-nonenal promotes cardiomyocyte necroptosis via stabilizing receptor-interacting serine\/threonine-protein kinase 1. Front Cell Dev Biol. 2021;9:721795.","journal-title":"Front Cell Dev Biol"},{"key":"7088_CR82","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1369\/0022155415574818","volume":"63","author":"XX Li","year":"2015","unstructured":"Li XX, Tsoi B, Li YF, Kurihara H, He RR. Cardiolipin and its different properties in mitophagy and apoptosis. J Histochem Cytochem. 2015;63:301\u201311.","journal-title":"J Histochem Cytochem"},{"key":"7088_CR83","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.ceca.2009.03.012","volume":"45","author":"G Paradies","year":"2009","unstructured":"Paradies G, Petrosillo G, Paradies V, Ruggiero FM. Role of cardiolipin peroxidation and Ca2+ in mitochondrial dysfunction and disease. Cell Calcium. 2009;45:643\u201350.","journal-title":"Cell Calcium"},{"key":"7088_CR84","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0378-1119(01)00814-9","volume":"286","author":"G Paradies","year":"2002","unstructured":"Paradies G, Petrosillo G, Pistolese M, Ruggiero FM. Reactive oxygen species affect mitochondrial electron transport complex I activity through oxidative cardiolipin damage. Gene. 2002;286:135\u201341.","journal-title":"Gene"},{"key":"7088_CR85","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1567-7249(01)00011-3","volume":"1","author":"G Paradies","year":"2001","unstructured":"Paradies G, Petrosillo G, Pistolese M, Ruggiero FM. Reactive oxygen species generated by the mitochondrial respiratory chain affect the complex III activity via cardiolipin peroxidation in beef-heart submitochondrial particles. Mitochondrion. 2001;1:151\u20139.","journal-title":"Mitochondrion"},{"key":"7088_CR86","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0014-5793(00)01082-6","volume":"466","author":"G Paradies","year":"2000","unstructured":"Paradies G, Petrosillo G, Pistolese M, Ruggiero FM. The effect of reactive oxygen species generated from the mitochondrial electron transport chain on the cytochrome c oxidase activity and on the cardiolipin content in bovine heart submitochondrial particles. FEBS Lett. 2000;466:323\u20136.","journal-title":"FEBS Lett"},{"key":"7088_CR87","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.005328","author":"H Zhou","year":"2017","unstructured":"Zhou H, Hu SY, Jin QH, Shi C, Zhang Y, Zhu PJ, et al. Mff-dependent mitochondrial fission contributes to the pathogenesis of cardiac microvasculature ischemia\/reperfusion injury via induction of mROS-mediated cardiolipin oxidation and HK2\/VDAC1 disassociation-involved mPTP opening. J Am Heart Assoc. 2017. https:\/\/doi.org\/10.1161\/JAHA.116.005328.","journal-title":"J Am Heart Assoc"},{"key":"7088_CR88","doi-asserted-by":"publisher","first-page":"34499","DOI":"10.1074\/jbc.M302021200","volume":"278","author":"LW Czerski","year":"2003","unstructured":"Czerski LW, Szweda PA, Szweda LI. Dissociation of cytochrome c from the inner mitochondrial membrane during cardiac ischemia. J Biol Chem. 2003;278:34499\u2013504.","journal-title":"J Biol Chem"},{"key":"7088_CR89","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1073\/pnas.241655498","volume":"99","author":"M Ott","year":"2002","unstructured":"Ott M, Robertson JD, Gogvadze V, Zhivotovsky B, Orrenius S. Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci USA. 2002;99:1259\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7088_CR90","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.dnarep.2007.01.003","volume":"6","author":"T Ohtsubo","year":"2007","unstructured":"Ohtsubo T, Ohya Y, Nakamura Y, Kansui Y, Furuichi M, Matsumura K, et al. Accumulation of 8-oxo-deoxyguanosine in cardiovascular tissues with the development of hypertension. DNA Repair. 2007;6:760\u20139.","journal-title":"DNA Repair"},{"key":"7088_CR91","doi-asserted-by":"publisher","first-page":"6229","DOI":"10.1093\/nar\/gkr164","volume":"39","author":"Q Wang","year":"2011","unstructured":"Wang Q, Liu JQ, Chen Z, Zheng KW, Chen CY, Hao YH, et al. G-quadruplex formation at the 3\u2019 end of telomere DNA inhibits its extension by telomerase, polymerase and unwinding by helicase. Nucleic Acids Res. 2011;39:6229\u201337.","journal-title":"Nucleic Acids Res"},{"key":"7088_CR92","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1101\/gad.313460.118","volume":"32","author":"W Ahmed","year":"2018","unstructured":"Ahmed W, Lingner J. PRDX1 and MTH1 cooperate to prevent ROS-mediated inhibition of telomerase. Genes Dev. 2018;32:658\u201369.","journal-title":"Genes Dev"},{"key":"7088_CR93","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1073\/pnas.94.2.514","volume":"94","author":"FM Yakes","year":"1997","unstructured":"Yakes FM, VanHouten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA. 1997;94:514\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7088_CR94","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1161\/01.RES.88.5.529","volume":"88","author":"T Ide","year":"2001","unstructured":"Ide T, Tsutsui H, Hayashidani S, Kang DC, Suematsu N, Nakamura K, et al. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res. 2001;88:529\u201335.","journal-title":"Circ Res"},{"key":"7088_CR95","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1161\/CIRCULATIONAHA.120.051923","volume":"144","author":"N Ale-Agha","year":"2021","unstructured":"Ale-Agha N, Jakobs P, Goy C, Zurek M, Rosen J, Dyballa-Rukes N, et al. Mitochondrial telomerase reverse transcriptase protects from myocardial ischemia\/reperfusion injury by improving complex I composition and function. Circulation. 2021;144:1876\u201390.","journal-title":"Circulation"},{"key":"7088_CR96","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ceca.2014.08.004","volume":"56","author":"L Pereira","year":"2014","unstructured":"Pereira L, Ruiz-Hurtado G, Rueda A, Mercadier J-J, Benitah J-P, Gomez AM. Calcium signaling in diabetic cardiomyocytes. Cell Calcium. 2014;56:372\u201380.","journal-title":"Cell Calcium"},{"key":"7088_CR97","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1111\/j.1582-4934.2010.01249.x","volume":"15","author":"Y Abdallah","year":"2011","unstructured":"Abdallah Y, Kasseckert SA, Iraqi W, Said M, Shahzad T, Erdogan A, et al. Interplay between Ca2+ cycling and mitochondrial permeability transition pores promotes reperfusion-induced injury of cardiac myocytes. J Cell Mol Med. 2011;15:2478\u201385.","journal-title":"J Cell Mol Med"},{"key":"7088_CR98","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/cvr\/cvp264","volume":"84","author":"MAH Talukder","year":"2009","unstructured":"Talukder MAH, Zweier JL, Periasamy M. Targeting calcium transport in ischaemic heart disease. Cardiovasc Res. 2009;84:345\u201352.","journal-title":"Cardiovasc Res"},{"key":"7088_CR99","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1152\/physrev.00024.2007","volume":"88","author":"E Murphy","year":"2008","unstructured":"Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev. 2008;88:581\u2013609.","journal-title":"Physiol Rev"},{"key":"7088_CR100","doi-asserted-by":"publisher","first-page":"114","DOI":"10.2174\/1573406411666150928112420","volume":"12","author":"GC Bompotis","year":"2016","unstructured":"Bompotis GC, Deftereos S, Angelidis C, Choidis E, Panagopoulou V, Kaoukis A, et al. Altered calcium handling in reperfusion injury. Med Chem. 2016;12:114\u201330.","journal-title":"Med Chem"},{"key":"7088_CR101","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1161\/01.CIR.98.21.2334","volume":"98","author":"DP Zipes","year":"1998","unstructured":"Zipes DP, Wellens HJJ. Sudden cardiac death. Circulation. 1998;98:2334\u201351.","journal-title":"Circulation"},{"key":"7088_CR102","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.bbabio.2010.01.005","volume":"1797","author":"J Santo-Domingo","year":"2010","unstructured":"Santo-Domingo J, Demaurex N. Calcium uptake mechanisms of mitochondria. BBA-Bioenergetics. 2010;1797:907\u201312.","journal-title":"BBA-Bioenergetics"},{"key":"7088_CR103","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nature10230","volume":"476","author":"D De Stefani","year":"2011","unstructured":"De Stefani D, Raffaello A, Teardo E, Szab\u00f2 I, Rizzuto R. A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature. 2011;476:336-U104.","journal-title":"Nature"},{"key":"7088_CR104","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/cvr\/cvs116","volume":"94","author":"D Garcia-Dorado","year":"2012","unstructured":"Garcia-Dorado D, Ruiz-Meana M, Inserte J, Rodriguez-Sinovas A, Piper HM. Calcium-mediated cell death during myocardial reperfusion. Cardiovasc Res. 2012;94:168\u201380.","journal-title":"Cardiovasc Res"},{"key":"7088_CR105","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10741-007-9039-9","volume":"12","author":"A Rodr\u00edguez-Sinovas","year":"2007","unstructured":"Rodr\u00edguez-Sinovas A, Abdallah Y, Piper HM, Garcia-Dorado D. Reperfusion injury as a therapeutic challenge in patients with acute myocardial infarction. Heart Fail Rev. 2007;12:207\u201316.","journal-title":"Heart Fail Rev"},{"key":"7088_CR106","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1021\/bi052475e","volume":"45","author":"RK Hopper","year":"2006","unstructured":"Hopper RK, Carroll S, Aponte AM, Johnson DT, French S, Shen RF, et al. Mitochondrial matrix phosphoproteome: effect of extra mitochondrial calcium. Biochemistry. 2006;45:2524\u201336.","journal-title":"Biochemistry"},{"key":"7088_CR107","doi-asserted-by":"publisher","first-page":"C817","DOI":"10.1152\/ajpcell.00139.2004","volume":"287","author":"PS Brookes","year":"2004","unstructured":"Brookes PS, Yoon YS, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol-Cell Physiol. 2004;287:C817\u201333.","journal-title":"Am J Physiol-Cell Physiol"},{"key":"7088_CR108","doi-asserted-by":"publisher","first-page":"638","DOI":"10.4330\/wjc.v6.i7.638","volume":"6","author":"C Neuhof","year":"2014","unstructured":"Neuhof C, Neuhof H. Calpain system and its involvement in myocardial ischemia and reperfusion injury. World J Cardiol. 2014;6:638\u201352.","journal-title":"World J Cardiol"},{"key":"7088_CR109","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/S0008-6363(03)00533-9","volume":"61","author":"AP Halestrap","year":"2004","unstructured":"Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection. Cardiovasc Res. 2004;61:372\u201385.","journal-title":"Cardiovasc Res"},{"key":"7088_CR110","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1161\/CIRCRESAHA.123.323882","volume":"134","author":"A Mendoza","year":"2024","unstructured":"Mendoza A, Patel P, Robichaux D, Ramirez D, Karch J. Inhibition of the mPTP and lipid peroxidation is additively protective against I\/R injury. Circ Res. 2024;134:1292\u2013305.","journal-title":"Circ Res"},{"key":"7088_CR111","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0002-9343(00)00467-8","volume":"109","author":"DJ Lefer","year":"2000","unstructured":"Lefer DJ, Granger DN. Oxidative stress and cardiac disease. Am J Med. 2000;109:315\u201323.","journal-title":"Am J Med"},{"key":"7088_CR112","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.cardiores.2003.09.025","volume":"60","author":"DJ Hausenloy","year":"2003","unstructured":"Hausenloy DJ, Duchen MR, Yellon DM. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res. 2003;60:617\u201325.","journal-title":"Cardiovasc Res"},{"key":"7088_CR113","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10863-009-9206-x","volume":"41","author":"AP Halestrap","year":"2009","unstructured":"Halestrap AP. Mitochondria and reperfusion injury of the heart-A holey death but not beyond salvation. J Bioenerg Biomembr. 2009;41:113\u201321.","journal-title":"J Bioenerg Biomembr"},{"key":"7088_CR114","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00395-009-0004-8","volume":"104","author":"CP Baines","year":"2009","unstructured":"Baines CP. The mitochondrial permeability transition pore and ischemia-reperfusion injury. Basic Res Cardiol. 2009;104:181\u20138.","journal-title":"Basic Res Cardiol"},{"key":"7088_CR115","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.bbadis.2019.05.007","volume":"1865","author":"M Yang","year":"2019","unstructured":"Yang M, Linn BS, Zhang Y, Ren J. Mitophagy and mitochondrial integrity in cardiac ischemia-reperfusion injury. BBA-Mol Basis Dis. 2019;1865:2293\u2013302.","journal-title":"BBA-Mol Basis Dis"},{"key":"7088_CR116","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.109.906610","volume":"121","author":"S-B Ong","year":"2010","unstructured":"Ong S-B, Subrayan S, Lim SY, Yellon DM, Davidson SM, Hausenloy DJ. Inhibiting mitochondrial fission protects the heart against ischemia\/reperfusion injury. Circulation. 2010;121:2012-U2107.","journal-title":"Circulation"},{"key":"7088_CR117","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41580-021-00332-2","volume":"22","author":"E Kummer","year":"2021","unstructured":"Kummer E, Ban NE. Mechanisms and regulation of protein synthesis in mitochondria. Nat Rev Mol Cell Biol. 2021;22:307\u201325.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7088_CR118","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1146\/annurev.bi.54.070185.005055","volume":"54","author":"Y Hatefi","year":"1985","unstructured":"Hatefi Y. The mitochondrial electron-transport and oxidative-phosphorylation system. Annu Rev Biochem. 1985;54:1015\u201369.","journal-title":"Annu Rev Biochem"},{"key":"7088_CR119","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","volume":"9","author":"Y Zong","year":"2024","unstructured":"Zong Y, Li H, Liao P, Chen L, Pan Y, Zheng YQ, et al. Mitochondrial dysfunction: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9:124.","journal-title":"Signal Transduct Target Ther"},{"key":"7088_CR120","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ab.2017.07.009","volume":"552","author":"LD Zorova","year":"2018","unstructured":"Zorova LD, Popkov VA, Plotnikov EY, Silachev DN, Pevzner IB, Jankauskas SS, et al. Mitochondrial membrane potential. Anal Biochem. 2018;552:50\u20139.","journal-title":"Anal Biochem"},{"key":"7088_CR121","doi-asserted-by":"publisher","first-page":"C137","DOI":"10.1152\/ajpcell.00270.2006","volume":"292","author":"Q Chen","year":"2007","unstructured":"Chen Q, Camara AKS, Stowe DF, Hoppel CL, Lesnefsky EJ. Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion. Am J Physiol-Cell Physiol. 2007;292:C137\u201347.","journal-title":"Am J Physiol-Cell Physiol"},{"key":"7088_CR122","doi-asserted-by":"publisher","first-page":"H1764","DOI":"10.1152\/ajpheart.00259.2014","volume":"307","author":"K He","year":"2014","unstructured":"He K, Yan L, Pan CS, Liu YY, Cui YC, Hu BH, et al. Rock-dependent ATP5D modulation contributes to the protection of notoginsenoside NR1 against ischemia-reperfusion-induced myocardial injury. Am J Physiol-Hear Circ Physiol. 2014;307:H1764\u201376.","journal-title":"Am J Physiol-Hear Circ Physiol"},{"key":"7088_CR123","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.yjmcc.2014.09.023","volume":"78","author":"P Bernardi","year":"2015","unstructured":"Bernardi P, Di Lisa F. The mitochondrial permeability transition pore: molecular nature and role as a target in cardioprotection. J Mol Cell Cardiol. 2015;78:100\u20136.","journal-title":"J Mol Cell Cardiol"},{"key":"7088_CR124","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/s41418-023-01187-0","volume":"30","author":"P Bernardi","year":"2023","unstructured":"Bernardi P, Gerle C, Halestrap AP, Jonas EA, Karch J, Mnatsakanyan N, et al. Identity, structure, and function of the mitochondrial permeability transition pore: controversies, consensus, recent advances, and future directions. Cell Death Differ. 2023;30:1869\u201385.","journal-title":"Cell Death Differ"},{"key":"7088_CR125","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/med.21635","volume":"40","author":"S Nesci","year":"2020","unstructured":"Nesci S. The mitochondrial permeability transition pore in cell death: a promising drug binding bioarchitecture. Med Res Rev. 2020;40:811\u20137.","journal-title":"Med Res Rev"},{"key":"7088_CR126","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-021-00433-y","volume":"23","author":"M Bonora","year":"2022","unstructured":"Bonora M, Giorgi C, Pinton P. Molecular mechanisms and consequences of mitochondrial permeability transition. Nat Rev Mol Cell Biol. 2022;23:266\u201385.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7088_CR127","first-page":"2003","volume":"8","author":"CY Guo","year":"2013","unstructured":"Guo CY, Sun L, Chen XP, Zhang DS. Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res. 2013;8:2003\u201314.","journal-title":"Neural Regen Res"},{"key":"7088_CR128","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1084\/jem.192.7.1001","volume":"192","author":"DB Zorov","year":"2000","unstructured":"Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med. 2000;192:1001\u201314.","journal-title":"J Exp Med"},{"key":"7088_CR129","doi-asserted-by":"publisher","first-page":"111212","DOI":"10.1016\/j.mad.2020.111212","volume":"186","author":"YJ Liu","year":"2020","unstructured":"Liu YJ, McIntyre RL, Janssens GE, Houtkooper RH. Mitochondrial fission and fusion: a dynamic role in aging and potential target for age-related disease. Mech Ageing Dev. 2020;186:111212.","journal-title":"Mech Ageing Dev"},{"key":"7088_CR130","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.yjmcc.2020.04.015","volume":"142","author":"MM Tong","year":"2020","unstructured":"Tong MM, Zablocki D, Sadoshima J. The role of Drp1 in mitophagy and cell death in the heart. J Mol Cell Cardiol. 2020;142:138\u201345.","journal-title":"J Mol Cell Cardiol"},{"key":"7088_CR131","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1111\/jcmm.13330","volume":"21","author":"C Maneechote","year":"2017","unstructured":"Maneechote C, Palee S, Chattipakorn SC, Chattipakorn N. Roles of mitochondrial dynamics modulators in cardiac ischaemia\/reperfusion injury. J Cell Mol Med. 2017;21:2643\u201353.","journal-title":"J Cell Mol Med"},{"key":"7088_CR132","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.1002\/jcp.27308","volume":"234","author":"H Zhou","year":"2019","unstructured":"Zhou H, Wang J, Hu SY, Zhu H, Toanc S, Ren J. BI1 alleviates cardiac microvascular ischemia-reperfusion injury via modifying mitochondrial fission and inhibiting XO\/ROS\/F-actin pathways. J Cell Physiol. 2019;234:5056\u201369.","journal-title":"J Cell Physiol"},{"key":"7088_CR133","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12413","author":"H Zhou","year":"2017","unstructured":"Zhou H, Zhang Y, Hu SY, Shi C, Zhu PJ, Ma Q, et al. Melatonin protects cardiac microvasculature against ischemia\/reperfusion injury via suppression of mitochondrial fission-VDAC1-HK2-mPTP-mitophagy axis. J Pineal Res. 2017. https:\/\/doi.org\/10.1111\/jpi.12413.","journal-title":"J Pineal Res"},{"issue":"S1","key":"7088_CR134","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.1038\/onc.2009.49","volume":"27","author":"G Chinnadurai","year":"2008","unstructured":"Chinnadurai G, Vijayalingam S, Gibson SB. BNIP3 subfamily BH3-only proteins: mitochondrial stress sensors in normal and pathological functions. Oncogene. 2008;27(S1):S114\u201327.","journal-title":"Oncogene"},{"key":"7088_CR135","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/ncb2422","volume":"14","author":"L Liu","year":"2012","unstructured":"Liu L, Feng D, Chen G, Chen M, Zheng QX, Song PP, et al. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat Cell Biol. 2012;14:177\u201385.","journal-title":"Nat Cell Biol"},{"key":"7088_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110148","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, Chen WY, Zhong ZH, Ding L, Bai H, Chen H, et al. Electroacupuncture preconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting mitophagy mediated by the mTORC1-ULK1-FUNDC1 pathway. Biomed Pharmacother. 2020. https:\/\/doi.org\/10.1016\/j.biopha.2020.110148.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"7088_CR137","doi-asserted-by":"publisher","first-page":"5543452","DOI":"10.1155\/2021\/5543452","volume":"2021","author":"J Huang","year":"2021","unstructured":"Huang J, Li RB, Wang CB. The role of mitochondrial quality control in cardiac ischemia\/reperfusion injury. Oxidative Med Cell Longevity. 2021;2021(1):5543452.","journal-title":"Oxidative Med Cell Longevity"},{"key":"7088_CR138","doi-asserted-by":"publisher","DOI":"10.3390\/antiox8100454","author":"AV Kuznetsov","year":"2019","unstructured":"Kuznetsov AV, Javadov S, Margreiter R, Grimm M, Hagenbuchner J, Ausserlechner MJ. The role of mitochondria in the mechanisms of cardiac ischemia-reperfusion injury. Antioxidants. 2019. https:\/\/doi.org\/10.3390\/antiox8100454.","journal-title":"Antioxidants"},{"key":"7088_CR139","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020614","author":"G Bisaccia","year":"2021","unstructured":"Bisaccia G, Ricci F, Gallina S, Di Baldassarre A, Ghinassi B. Mitochondrial dysfunction and heart disease: critical appraisal of an overlooked association. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22020614.","journal-title":"Int J Mol Sci"},{"key":"7088_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105407","author":"O Faust","year":"2022","unstructured":"Faust O, Hong W, Loh HW, Xu S, Tan R-S, Chakraborty S, et al. Heart rate variability for medical decision support systems: a review. Comput Biol Med. 2022. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.105407.","journal-title":"Comput Biol Med"},{"key":"7088_CR141","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-023-01018-w","author":"SX Chen","year":"2023","unstructured":"Chen SX, Zou YM, Song CY, Cao KX, Cai KX, Wu YJ, et al. The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches. Basic Res Cardiol. 2023. https:\/\/doi.org\/10.1007\/s00395-023-01018-w.","journal-title":"Basic Res Cardiol"},{"key":"7088_CR142","doi-asserted-by":"publisher","first-page":"E78","DOI":"10.1161\/01.RES.0000129255.19569.8f","volume":"94","author":"JRB Dyck","year":"2004","unstructured":"Dyck JRB, Cheng JF, Stanley WC, Barr R, Chandler MP, Brown S, et al. Malonyl coenzyme A decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation. Circ Res. 2004;94:E78\u201384.","journal-title":"Circ Res"},{"key":"7088_CR143","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/0002-9149(62)90035-8","volume":"9","author":"D Sodipallares","year":"1962","unstructured":"Sodipallares D, Demicheli A, Fishleder BL, Friedland C, Bisteni A, Testelli MR, et al. Effects of an intravenous infusion of a potassium-glucose-insulin solution on electrocardiographic signs of myocardial infarction. Am J Cardiol. 1962;9:166.","journal-title":"Am J Cardiol"},{"key":"7088_CR144","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1161\/CIRCULATIONAHA.112.130625","volume":"127","author":"AN Grossman","year":"2013","unstructured":"Grossman AN, Opie LH, Beshansky JR, Ingwall JS, Rackley CE, Selker HP. Glucose-insulin-potassium revived current status in acute coronary syndromes and the energy-depleted heart. Circulation. 2013;127:1040\u20138.","journal-title":"Circulation"},{"key":"7088_CR145","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20221212","author":"A Clerk","year":"2022","unstructured":"Clerk A, Sugden PH. The insulin receptor family in the heart: new light on old insights. 2022. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20221212."},{"key":"7088_CR146","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1016\/j.jacc.2022.03.353","volume":"79","author":"JA Udell","year":"2022","unstructured":"Udell JA, Jones WS, Petrie MC, Harrington J, Anker SD, Bhatt DL, et al. Sodium glucose cotransporter-2 inhibition for acute myocardial infarction JACC review topic of the week. J Am Coll Cardiol. 2022;79:2058\u201368.","journal-title":"J Am Coll Cardiol"},{"key":"7088_CR147","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s13238-020-00809-4","volume":"13","author":"K Jiang","year":"2022","unstructured":"Jiang K, Xu Y, Wang DD, Chen F, Tu ZZ, Qian J, et al. Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis. Protein Cell. 2022;13:336\u201359.","journal-title":"Protein Cell"},{"key":"7088_CR148","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1161\/CIRCULATIONAHA.122.061688","volume":"147","author":"S Chen","year":"2023","unstructured":"Chen S, Wang Q, Christodoulou A, Mylonas N, Bakker D, Nederlof R, et al. Sodium glucose cotransporter-2 inhibitor empagliflozin reduces infarct size independently of sodium glucose cotransporter-2. Circulation. 2023;147:276\u20139.","journal-title":"Circulation"},{"key":"7088_CR149","first-page":"H1079","volume":"259","author":"JJ McVeigh","year":"1990","unstructured":"McVeigh JJ, Lopaschuk GD. Dichloroacetate stimulation of glucose-oxidation improves recovery of ischemic rat hearts. Am J Physiol. 1990;259:H1079\u201385.","journal-title":"Am J Physiol"},{"key":"7088_CR150","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1161\/01.CIR.91.7.2071","volume":"91","author":"ED Lewandowski","year":"1995","unstructured":"Lewandowski ED, White LT. Pyruvate-dehydrogenase influences postischemic heart function. Circulation. 1995;91:2071\u20139.","journal-title":"Circulation"},{"key":"7088_CR151","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/toxsci\/kfy272","volume":"167","author":"X Li","year":"2019","unstructured":"Li X, Liu J, Hu HY, Lu SX, Lu QG, Quan NH, et al. Dichloroacetate ameliorates cardiac dysfunction caused by ischemic insults through AMPK signal pathway not only shifts metabolism. Toxicol Sci. 2019;167:604\u201317.","journal-title":"Toxicol Sci"},{"key":"7088_CR152","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032345","volume":"24","author":"N Wagner","year":"2023","unstructured":"Wagner N, Wagner KD. Pharmacological utility of PPAR modulation for angiogenesis in cardiovascular disease. Int J Mol Sci. 2023;24:.","journal-title":"Int J Mol Sci"},{"key":"7088_CR153","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.2337\/diabetes.51.4.1110","volume":"51","author":"RJ Sidell","year":"2002","unstructured":"Sidell RJ, Cole MA, Draper NJ, Desrois M, Buckingham RE, Clarke K. Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the Zucker fatty rat heart. Diabetes. 2002;51:1110\u20137.","journal-title":"Diabetes"},{"key":"7088_CR154","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1210\/en.2005-1433","volume":"147","author":"J Yang","year":"2006","unstructured":"Yang J, Holman GD. Long-term metformin treatment stimulates cardiomyocyte glucose transport through an AMP-activated protein kinase-dependent reduction in GLUT4 endocytosis. Endocrinology. 2006;147:2728\u201336.","journal-title":"Endocrinology"},{"key":"7088_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123115","author":"HM El-Abasy","year":"2024","unstructured":"El-Abasy HM, Elsaid MEA, Abdelkader EM, Shehatou GSG. Metformin\u2019s cardioprotective role in isoprenaline-induced myocardial infarction: unveiling insights into the AMPK, NF-\u03baB, JAK2\/STAT3 pathways, and cholinergic regulation. Life Sci. 2024. https:\/\/doi.org\/10.1016\/j.lfs.2024.123115.","journal-title":"Life Sci"},{"key":"7088_CR156","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11154-014-9286-8","volume":"15","author":"J Hansen","year":"2014","unstructured":"Hansen J, Brock B, Botker HE, Gjedde A, Rungby J, Gejl M. Impact of glucagon-like peptide-1 on myocardial glucose metabolism revisited. Rev Endocr Metab Disord. 2014;15:219\u201331.","journal-title":"Rev Endocr Metab Disord"},{"key":"7088_CR157","first-page":"161","volume":"23","author":"G Zhou","year":"2023","unstructured":"Zhou G, Wu H, Yang J, Ye M, Liu D, Li YZ, et al. Liraglutide attenuates myocardial ischemia\/reperfusion injury through the inhibition of necroptosis by activating GLP-1R\/PI3K\/Akt pathway. Cardiovasc Toxicol. 2023;23:161\u201375.","journal-title":"Cardiovasc Toxicol"},{"key":"7088_CR158","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/cvr\/cvs129","volume":"94","author":"JR Ussher","year":"2012","unstructured":"Ussher JR, Wang W, Gandhi M, Keung W, Samokhvalov V, Oka T, et al. Stimulation of glucose oxidation protects against acute myocardial infarction and reperfusion injury. Cardiovasc Res. 2012;94:359\u201369.","journal-title":"Cardiovasc Res"},{"key":"7088_CR159","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1136\/hrt.2009.190256","volume":"96","author":"RM Beadle","year":"2010","unstructured":"Beadle RM, Frenneaux M. Modification of myocardial substrate utilisation: a new therapeutic paradigm in cardiovascular disease. Heart. 2010;96:824\u201330.","journal-title":"Heart"},{"key":"7088_CR160","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/cvr\/cvn130","volume":"79","author":"JR Ussher","year":"2008","unstructured":"Ussher JR, Lopaschuk GD. The malonyl CoA axis as a potential target for treating ischaemic heart disease. Cardiovasc Res. 2008;79:259\u201368.","journal-title":"Cardiovasc Res"},{"key":"7088_CR161","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1161\/CIRCULATIONAHA.106.642009","volume":"114","author":"JRB Dyck","year":"2006","unstructured":"Dyck JRB, Hopkins TA, Bonnet S, Michelakis ED, Young ME, Watanabe M, et al. Absence of malonyl coenzyme a decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury. Circulation. 2006;114:1721\u20138.","journal-title":"Circulation"},{"key":"7088_CR162","first-page":"385","volume":"4","author":"W Wang","year":"2019","unstructured":"Wang W, Zhang LY, Battiprolu PK, Fukushima A, Nguyen K, Milner K, et al. Malonyl CoA decarboxylase inhibition improves cardiac function post-myocardial infarction. Jacc-Basic Transl Sci. 2019;4:385\u2013400.","journal-title":"Jacc-Basic Transl Sci"},{"key":"7088_CR163","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s00210-023-02469-7","volume":"396","author":"MH Farzaei","year":"2023","unstructured":"Farzaei MH, Ramezani-Aliakbari F, Ramezani-Aliakbari M, Zarei M, Komaki A, Shahidi S, et al. Regulatory effects of trimetazidine in cardiac ischemia\/reperfusion injury. Naunyn-Schmiedebergs Arch Pharmacol. 2023;396:1633\u201346.","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"7088_CR164","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10557-021-07259-y","volume":"37","author":"G Qian","year":"2023","unstructured":"Qian G, Xin A, Jiang XS, Jiang ZC, Li T, Dong W, et al. Early Trimetazidine therapy in patients undergoing primary percutaneous coronary intervention for ST segment elevation myocardial infarction reduces myocardial infarction size. Cardiovasc Drugs Ther. 2023;37:497\u2013506.","journal-title":"Cardiovasc Drugs Ther"},{"key":"7088_CR165","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000000862","author":"M Kallash","year":"2025","unstructured":"Kallash M, Frishman WH. Trimetazidine use in cardiovascular disease. Cardiol Rev. 2025. https:\/\/doi.org\/10.1097\/CRD.0000000000000862.","journal-title":"Cardiol Rev"},{"key":"7088_CR166","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109106","author":"HY Hu","year":"2019","unstructured":"Hu HY, Li X, Ren D, Tan Y, Chen JM, Yang L, et al. The cardioprotective effects of carvedilol on ischemia and reperfusion injury by AMPK signaling pathway. Biomed Pharmacother. 2019. https:\/\/doi.org\/10.1016\/j.biopha.2019.109106.","journal-title":"Biomed Pharmacother"},{"key":"7088_CR167","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/bph.13004","volume":"172","author":"E Liepinsh","year":"2015","unstructured":"Liepinsh E, Makrecka-Kuka M, Kuka J, Vilskersts R, Makarova E, Cirule H, et al. Inhibition of L-carnitine biosynthesis and transport by methyl-\u03b3-butyrobetaine decreases fatty acid oxidation and protects against myocardial infarction. Br J Pharmacol. 2015;172:1319\u201332.","journal-title":"Br J Pharmacol"},{"key":"7088_CR168","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.freeradbiomed.2024.11.054","volume":"227","author":"YQ Cai","year":"2025","unstructured":"Cai YQ, Yu YF, Zhang TL, Qian BS, Wang BL, Yan WX, et al. GATAD1 is involved in sphingosylphosphorylcholine-attenuated myocardial ischemia-reperfusion injury by modulating myocardial fatty acid oxidation and glucose oxidation. Free Radic Biol Med. 2025;227:166\u201378.","journal-title":"Free Radic Biol Med"},{"key":"7088_CR169","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00395-024-01063-z","volume":"119","author":"J Abe","year":"2024","unstructured":"Abe J, Vujic A, Prag HA, Murphy MP, Krieg T. Malonate given at reperfusion prevents post-myocardial infarction heart failure by decreasing ischemia\/reperfusion injury. Basic Res Cardiol. 2024;119:691\u20137.","journal-title":"Basic Res Cardiol"},{"key":"7088_CR170","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1113\/JP273408","volume":"595","author":"NR Jespersen","year":"2017","unstructured":"Jespersen NR, Yokota T, Stottrup NB, Bergdahl A, Paelestik KB, Povlsen JA, et al. Pre-ischaemic mitochondrial substrate constraint by inhibition of malate-aspartate shuttle preserves mitochondrial function after ischaemia-reperfusion. J Physiol-Lond. 2017;595:3765\u201380.","journal-title":"J Physiol-Lond"},{"key":"7088_CR171","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/cvr\/cvq205","volume":"88","author":"NB Stottrup","year":"2010","unstructured":"Stottrup NB, Lofgren B, Birkler RD, Nielsen JM, Wang L, Caldarone CA, et al. Inhibition of the malate-aspartate shuttle by pre-ischaemic aminooxyacetate loading of the heart induces cardioprotection. Cardiovasc Res. 2010;88:257\u201366.","journal-title":"Cardiovasc Res"},{"key":"7088_CR172","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1179\/135100010X12826446921464","volume":"15","author":"M Pilar Valdecantos","year":"2010","unstructured":"Pilar Valdecantos M, Perez-Matute P, Quintero P, Alfredo MJ. Vitamin C, resveratrol and lipoic acid actions on isolated rat liver mitochondria: all antioxidants but different. Redox Rep. 2010;15:207\u201316.","journal-title":"Redox Rep"},{"key":"7088_CR173","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063114","author":"HB Zheng","year":"2024","unstructured":"Zheng HB, Xu YC, Liehn EA, Rusu M. Vitamin c as scavenger of reactive oxygen species during healing after myocardial infarction. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25063114.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"7088_CR174","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.3390\/nu12082199","volume":"12","author":"SA Khan","year":"2020","unstructured":"Khan SA, Bhattacharjee S, Ghani MOA, Walden R, Chen QM. Vitamin C for cardiac protection during percutaneous coronary intervention: a systematic review of randomized controlled trials. Nutrients. 2020;12(8):2199.","journal-title":"Nutrients"},{"key":"7088_CR175","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.yjmcc.2019.08.010","volume":"135","author":"JB Perry","year":"2019","unstructured":"Perry JB, Davis GN, Allen ME, Makrecka-Kuka M, Dambrova M, Grange RW, et al. Cardioprotective effects of idebenone do not involve ROS scavenging: evidence for mitochondrial complex I bypass in ischemia\/reperfusion injury. J Mol Cell Cardiol. 2019;135:160\u201371.","journal-title":"J Mol Cell Cardiol"},{"key":"7088_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175569","author":"DM Li","year":"2023","unstructured":"Li DM, Zhang G, Wang ZY, Guo JC, Liu Y, Lu YZ, et al. Idebenone attenuates ferroptosis by inhibiting excessive autophagy via the ROS-AMPK-mTOR pathway to preserve cardiac function after myocardial infarction. Eur J Pharmacol. 2023. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175569.","journal-title":"Eur J Pharmacol"},{"key":"7088_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154222","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Zhao XR, Gao M, Xu LA, Qi Y, Wang JH, et al. Dioscin alleviates myocardial infarction injury via regulating BMP4\/ NOX1-mediated oxidative stress and inflammation. Phytomedicine. 2022. https:\/\/doi.org\/10.1016\/j.phymed.2022.154222.","journal-title":"Phytomedicine"},{"key":"7088_CR178","doi-asserted-by":"publisher","first-page":"783426","DOI":"10.3389\/fcvm.2022.783426","volume":"9","author":"TY Shen","year":"2022","unstructured":"Shen TY, Lyu D, Zhang MP, Shang H, Lu QL. Dioscin alleviates cardiac dysfunction in acute myocardial infarction via rescuing mitochondrial malfunction. Front Cardiovasc Med. 2022;9:783426.","journal-title":"Front Cardiovasc Med"},{"key":"7088_CR179","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1089\/ars.2018.7624","volume":"31","author":"L Jiang","year":"2019","unstructured":"Jiang L, Zeng H, Ni L, Qi L, Xu Y, Xia L, et al. HIF-1\u03b1 preconditioning potentiates antioxidant activity in ischemic injury: the role of sequential administration of dihydrotanshinone I and protocatechuic aldehyde in cardioprotection. Antioxid Redox Signal. 2019;31:227\u201342.","journal-title":"Antioxid Redox Signal"},{"key":"7088_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173723","author":"Y-J Wan","year":"2021","unstructured":"Wan Y-J, Wang Y-H, Guo Q, Jiang Y, Tu P-F, Zeng K-W. Protocatechualdehyde protects oxygen-glucose deprivation\/reoxygenation-induced myocardial injury via inhibiting PERK\/ATF6\u03b1\/IRE1\u03b1 pathway. Eur J Pharmacol. 2021. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173723.","journal-title":"Eur J Pharmacol"},{"key":"7088_CR181","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13287-023-03615-x","volume":"15","author":"JT Fang","year":"2024","unstructured":"Fang JT, Yang QB, Maas RGC, Buono M, Meijlink B, Bruinenberg DL, et al. Vitamin C facilitates direct cardiac reprogramming by inhibiting reactive oxygen species. Stem Cell Res Ther. 2024;15:19.","journal-title":"Stem Cell Res Ther"},{"key":"7088_CR182","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1179\/135100010X12826446921464","volume":"15","author":"MP Valdecantos","year":"2010","unstructured":"Valdecantos MP, P\u00e9rez-Matute P, Quintero P, Mart\u00ednez JA. Vitamin C, resveratrol and lipoic acid actions on isolated rat liver mitochondria: all antioxidants but different. Redox Rep. 2010;15:207\u201316.","journal-title":"Redox Rep"},{"key":"7088_CR183","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1213\/ANE.0000000000006487","volume":"137","author":"Z-R Chen","year":"2023","unstructured":"Chen Z-R, Hong Y, Wen S-H, Zhan Y-Q, Huang W-Q. Dexmedetomidine pretreatment protects against myocardial ischemia\/reperfusion injury by activating STAT3 signaling. Anesth Analg. 2023;137:426\u201339.","journal-title":"Anesth Analg"},{"key":"7088_CR184","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409499","author":"H She","year":"2024","unstructured":"She H, Hu Y, Zhao G, Du Y, Wu Y, Chen W, et al. Dexmedetomidine ameliorates myocardial ischemia-reperfusion injury by inhibiting MDH2 lactylation via regulating metabolic reprogramming. Adv Sci. 2024. https:\/\/doi.org\/10.1002\/advs.202409499.","journal-title":"Adv Sci"},{"key":"7088_CR185","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3390\/ph16101473","volume":"16","author":"FS Tallo","year":"2023","unstructured":"Tallo FS, de Santana PO, Pinto SAG, Lima RY, de Araujo EA, Tavares JGP, et al. Pharmacological modulation of the Ca2+\/cAMP\/adenosine signaling in cardiac cells as a new cardioprotective strategy to reduce severe arrhythmias in myocardial infarction. Pharmaceuticals. 2023;16:1473.","journal-title":"Pharmaceuticals"},{"key":"7088_CR186","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.822640","author":"M Bao","year":"2022","unstructured":"Bao M, Huang W, Zhao Y, Fang X, Zhang Y, Gao F, et al. Verapamil alleviates myocardial ischemia\/reperfusion injury by attenuating oxidative stress via activation of SIRT1. Front Pharmacol. 2022. https:\/\/doi.org\/10.3389\/fphar.2022.822640.","journal-title":"Front Pharmacol"},{"key":"7088_CR187","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s00125-017-4509-7","volume":"61","author":"L Uthman","year":"2018","unstructured":"Uthman L, Baartscheer A, Bleijlevens B, Schumacher CA, Fiolet JWT, Koeman A, et al. Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+\/H+ exchanger, lowering of cytosolic Na+ and vasodilation. Diabetologia. 2018;61:722\u20136.","journal-title":"Diabetologia"},{"key":"7088_CR188","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158541","author":"Y-H Lin","year":"2024","unstructured":"Lin Y-H, Tsai W-C, Chiu C-C, Chi N-Y, Liu Y-H, Huang T-C, et al. The beneficial effect of the SGLT2 inhibitor Dapagliflozin in alleviating acute myocardial infarction-induced cardiomyocyte injury by increasing the Sirtuin family SIRT1\/SIRT3 and cascade signaling. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25158541.","journal-title":"Int J Mol Sci"},{"key":"7088_CR189","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.682273","author":"Y Li","year":"2021","unstructured":"Li Y, Zhang Z, Li S, Yu T, Jia Z. Therapeutic effects of traditional Chinese medicine on cardiovascular diseases: the central role of calcium signaling. Front Pharmacol. 2021. https:\/\/doi.org\/10.3389\/fphar.2021.682273.","journal-title":"Front Pharmacol"},{"key":"7088_CR190","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bbabio.2011.11.021","volume":"1817","author":"AK Gadicherla","year":"2012","unstructured":"Gadicherla AK, Stowe DF, Antholine WE, Yang MY, Camara AKS. Damage to mitochondrial complex I during cardiac ischemia reperfusion injury is reduced indirectly by anti-anginal drug ranolazine. Biochim Biophys Acta (BBA). 2012;1817:419\u201329.","journal-title":"Biochim Biophys Acta (BBA)"},{"key":"7088_CR191","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1053\/j.semtcvs.2021.01.004","volume":"34","author":"I Samiotis","year":"2022","unstructured":"Samiotis I, Papakonstantinou NA, Dedeilias P, Vasileiadis I, Papalois A, Deftereos S, et al. Dantrolene induces mitigation of myocardial ischemia-reperfusion injury by ryanodine receptor inhibition. Semin Thorac Cardiovasc Surg. 2022;34:123\u201332.","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"7088_CR192","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.yjmcc.2023.03.007","volume":"178","author":"S Fujii","year":"2023","unstructured":"Fujii S, Kobayashi S, Chang YW, Nawata J, Yoshitomi R, Tanaka S, et al. RyR2-targeting therapy prevents left ventricular remodeling and ventricular tachycardia in post-infarction heart failure. J Mol Cell Cardiol. 2023;178:36\u201350.","journal-title":"J Mol Cell Cardiol"},{"key":"7088_CR193","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nature03317","volume":"434","author":"T Nakagawa","year":"2005","unstructured":"Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H, et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature. 2005;434:652\u20138.","journal-title":"Nature"},{"key":"7088_CR194","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nature03434","volume":"434","author":"CP Baines","year":"2005","unstructured":"Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature. 2005;434:658\u201362.","journal-title":"Nature"},{"key":"7088_CR195","first-page":"e011846","volume":"17","author":"Z Kiernan","year":"2024","unstructured":"Kiernan Z, Labate G, Chen Q, Lesnefsky EJ, Quader M. Infarct size reduction with cyclosporine A in circulatory death rat hearts: reducing effective ischemia time with therapy during reperfusion. Circ-Hear Failure. 2024;17:e011846.","journal-title":"Circ-Hear Failure"},{"key":"7088_CR196","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-021-03270-w","author":"H Tai","year":"2021","unstructured":"Tai H, Jiang X-l, Lan Z-m, Li Y, Kong L, Yao S-c, et al. Tanshinone IIA combined with CsA inhibit myocardial cell apoptosis induced by renal ischemia-reperfusion injury in obese rats. BMC Complement Med Ther. 2021. https:\/\/doi.org\/10.1186\/s12906-021-03270-w.","journal-title":"BMC Complement Med Ther"},{"key":"7088_CR197","first-page":"1379","volume":"42","author":"S Liu","year":"2018","unstructured":"Liu S, Wu N, Miao J, Huang Z, Li X, Jia P, et al. Protective effect of morin on myocardial ischemia-reperfusion injury in rats. Int J Mol Med. 2018;42:1379\u201390.","journal-title":"Int J Mol Med"},{"key":"7088_CR198","first-page":"2581","volume":"19","author":"Q-J Qin","year":"2019","unstructured":"Qin Q-J, Cui L-Q, Li P, Wang Y-B, Zhang X-Z, Guo M-L. Rhynchophylline ameliorates myocardial ischemia\/reperfusion injury through the modulation of mitochondrial mechanisms to mediate myocardial apoptosis. Mol Med Rep. 2019;19:2581\u201390.","journal-title":"Mol Med Rep"},{"key":"7088_CR199","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/FJC.0000000000000969","volume":"77","author":"A Schauer","year":"2021","unstructured":"Schauer A, Barthel P, Adams V, Linke A, Poitz DM, Weinbrenner C. Pharmacological pre- and postconditioning with Levosimendan protect H9c2 cardiomyoblasts from anoxia\/reoxygenation-induced cell death via PI3K\/Akt signaling. J Cardiovasc Pharmacol. 2021;77:378\u201385.","journal-title":"J Cardiovasc Pharmacol"},{"key":"7088_CR200","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105986","author":"AR Bland","year":"2022","unstructured":"Bland AR, Payne FM, Ashton JC, Jamialahmadi T, Sahebkar A. The cardioprotective actions of statins in targeting mitochondrial dysfunction associated with myocardial ischaemia-reperfusion injury. Pharmacol Res. 2022. https:\/\/doi.org\/10.1016\/j.phrs.2021.105986.","journal-title":"Pharmacol Res"},{"key":"7088_CR201","doi-asserted-by":"publisher","first-page":"E131","DOI":"10.1097\/CCM.0000000000001350","volume":"44","author":"SG Qiao","year":"2016","unstructured":"Qiao SG, Mao XW, Wang Y, Lei SQ, Liu YN, Wang TT, et al. Remifentanil preconditioning reduces postischemic myocardial infarction and improves left ventricular performance via activation of the Janus Activated Kinase-2\/Signal Transducers and Activators of Transcription-3 signal pathway and subsequent inhibition of Glycogen Synthase Kinase-3\u03b2 in rats. Crit Care Med. 2016;44:E131\u201345.","journal-title":"Crit Care Med"},{"key":"7088_CR202","first-page":"125","volume":"71","author":"GM Albadrani","year":"2020","unstructured":"Albadrani GM, Binmowyna MN, Bin-Jumah MN, El-Akabawy G, Aldera H, Al-Farga AM. Quercetin protects against experimentally-induced myocardial infarction in rats by an antioxidant potential and concomitant activation of signal transducer and activator of transcription 3. J Physiol Pharmacol. 2020;71:125.","journal-title":"J Physiol Pharmacol"},{"key":"7088_CR203","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/1755-5922.12225","volume":"35","author":"CW Liu","year":"2017","unstructured":"Liu CW, Yang F, Cheng SZ, Liu Y, Wan LH, Cong HL. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: the role of radical oxygen species, PI3K-Akt-GSK-3 pathway, and mitochondrial permeability transition pore. Cardiovasc Ther. 2017;35:3\u20139.","journal-title":"Cardiovasc Ther"},{"key":"7088_CR204","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05979-x","author":"BL Zuo","year":"2024","unstructured":"Zuo BL, Li XY, Xu DW, Zhao LP, Yang Y, Luan Y, et al. Targeting mitochondrial transfer: a new horizon in cardiovascular disease treatment. J Transl Med. 2024. https:\/\/doi.org\/10.1186\/s12967-024-05979-x.","journal-title":"J Transl Med"},{"key":"7088_CR205","first-page":"871","volume":"4","author":"B Shin","year":"2019","unstructured":"Shin B, Saeed MY, Esch JJ, Guariento A, Blitzer D, Moskowitzova K, et al. A novel biological strategy for myocardial protection by intracoronary delivery of mitochondria: safety and efficacy. JACC: Basic Transl Sci. 2019;4:871\u201388.","journal-title":"JACC: Basic Transl Sci"},{"key":"7088_CR206","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jtcvs.2017.02.018","volume":"154","author":"SM Emani","year":"2017","unstructured":"Emani SM, Piekarski BL, Harrild D, del Nido PJ, McCully JD. Autologous mitochondrial transplantation for dysfunction after ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 2017;154:286\u20139.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"7088_CR207","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04203-6","author":"MC Sun","year":"2023","unstructured":"Sun MC, Jiang WH, Mu N, Zhang ZH, Yu L, Ma H. Mitochondrial transplantation as a novel therapeutic strategy for cardiovascular diseases. J Transl Med. 2023. https:\/\/doi.org\/10.1186\/s12967-023-04203-6.","journal-title":"J Transl Med"},{"key":"7088_CR208","doi-asserted-by":"publisher","DOI":"10.1177\/09636897221148457","author":"D Mori","year":"2023","unstructured":"Mori D, Miyagawa S, Kawamura T, Yoshioka D, Hata H, Ueno T, et al. Mitochondrial transfer induced by Adipose-derived mesenchymal stem cell transplantation improves cardiac function in rat models of ischemic cardiomyopathy. Cell Transplant. 2023. https:\/\/doi.org\/10.1177\/09636897221148457.","journal-title":"Cell Transplant"},{"key":"7088_CR209","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/s41565-024-01681-7","volume":"19","author":"ZY Wu","year":"2024","unstructured":"Wu ZY, Chen L, Guo WY, Wang J, Ni HY, Liu JN, et al. Oral mitochondrial transplantation using nanomotors to treat ischaemic heart disease. Nat Nanotechnol. 2024;19:1375\u201385.","journal-title":"Nat Nanotechnol"},{"key":"7088_CR210","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/s41565-024-01678-2","volume":"19","author":"C Gorick","year":"2024","unstructured":"Gorick C, Debski A. Mitochondrial transplantation for ischemic heart disease. Nat Nanotechnol. 2024;19:1247\u20138.","journal-title":"Nat Nanotechnol"},{"key":"7088_CR211","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-020-0809-z","author":"Y Sawashita","year":"2020","unstructured":"Sawashita Y, Hirata N, Yoshikawa Y, Terada H, Tokinaga Y, Yamakage M. Remote ischemic preconditioning reduces myocardial ischemia-reperfusion injury through unacylated ghrelin-induced activation of the JAK\/STAT pathway. Basic Res Cardiol. 2020. https:\/\/doi.org\/10.1007\/s00395-020-0809-z.","journal-title":"Basic Res Cardiol"},{"key":"7088_CR212","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/cvr\/cvq258","volume":"88","author":"A Gonzalez-Loyola","year":"2010","unstructured":"Gonzalez-Loyola A, Barba I. Mitochondrial metabolism revisited: a route to cardioprotection. Cardiovasc Res. 2010;88:209\u201310.","journal-title":"Cardiovasc Res"},{"key":"7088_CR213","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/jamacardio.2017.0022","volume":"2","author":"T Engstrom","year":"2017","unstructured":"Engstrom T, Kelbaek H, Helqvist S, Hofsten DE, Klovgaard L, Clemmensen P, et al. Effect of ischemic postconditioning during primary percutaneous coronary intervention for patients with ST-segment elevation myocardial infarction a randomized clinical trial. Jama Cardiology. 2017;2:490\u20137.","journal-title":"Jama Cardiology"},{"key":"7088_CR214","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1042\/BJ20051927","volume":"395","author":"SM Nadtochiy","year":"2006","unstructured":"Nadtochiy SM, Tompkins AJ, Brookes PS. Different mechanisms of mitochondrial proton leak in ischaemia\/reperfusion injury and preconditioning: implications for pathology and cardioprotection. Biochem J. 2006;395:611\u20138.","journal-title":"Biochem J"},{"key":"7088_CR215","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1161\/01.RES.0000012567.95445.55","volume":"90","author":"HY Tong","year":"2002","unstructured":"Tong HY, Imahashi K, Steenbergen C, Murphy E. Phosphorylation of glycogen synthase kinase-3\u03b2 during preconditioning through a phosphatidylinositol-3-kinase-dependent pathway is cardioprotective. Circ Res. 2002;90:377\u20139.","journal-title":"Circ Res"},{"key":"7088_CR216","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1161\/01.RES.0000178451.08719.5b","volume":"97","author":"ADT Costa","year":"2005","unstructured":"Costa ADT, Garlid KD, West IC, Lincoln TM, Downey JM, Cohen MV, et al. Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res. 2005;97:329\u201336.","journal-title":"Circ Res"},{"key":"7088_CR217","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1016\/S0021-9258(17)34720-8","volume":"253","author":"JT Whitmer","year":"1978","unstructured":"Whitmer JT, Idellwenger JA, Rovetto MJ, Neely JR. Control of fatty-acid metabolism in ischemic and hypoxic hearts. J Biol Chem. 1978;253:4305\u20139.","journal-title":"J Biol Chem"},{"key":"7088_CR218","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/0014-5793(89)80141-3","volume":"243","author":"V Borutaite","year":"1989","unstructured":"Borutaite V, Mildaziene V, Ivanoviene L, Kholodenko B, Toleikis A, Praskevicius A. The role of long-chain acyl-CoA in the damage of oxidative-phosphorylation in heart-mitochondria. FEBS Lett. 1989;243:264\u20136.","journal-title":"FEBS Lett"},{"key":"7088_CR219","doi-asserted-by":"publisher","first-page":"e21765","DOI":"10.1096\/fj.202100394R","volume":"35","author":"M Kerr","year":"2021","unstructured":"Kerr M, Dennis K, Carr CA, Fuller W, Berridge G, Rohling S, et al. Diabetic mitochondria are resistant to palmitoyl CoA inhibition of respiration, which is detrimental during ischemia. Faseb J. 2021;35:e21765.","journal-title":"Faseb J"},{"key":"7088_CR220","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-76045-1","author":"ZY Ou","year":"2024","unstructured":"Ou ZY, Yang L, Wu JY, Xu MX, Weng XQ, Xu GQ. Metabolic characteristics of ischaemic preconditioning induced performance improvement in Taekwondo athletes using LC-MS\/MS-based plasma metabolomics. Sci Rep. 2024. https:\/\/doi.org\/10.1038\/s41598-024-76045-1.","journal-title":"Sci Rep"},{"key":"7088_CR221","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/00019501-199304000-00011","volume":"4","author":"BZ Simkhovich","year":"1993","unstructured":"Simkhovich BZ, Hale SL, Ovize M, Przyklenk K, Kloner RA. Ischemic preconditioning and long-chain acyl carnitine in the canine heart. Coron Artery Dis. 1993;4:387\u201392.","journal-title":"Coron Artery Dis"},{"key":"7088_CR222","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0008-6363(01)00313-3","volume":"51","author":"R Lango","year":"2001","unstructured":"Lango R, Smolenski RT, Narkiewicz M, Suchorzewska J, Lysiak-Szydlowska W. Influence of L-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass. Cardiovasc Res. 2001;51:21\u20139.","journal-title":"Cardiovasc Res"},{"key":"7088_CR223","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/toxsci\/kfx193","volume":"160","author":"M Xue","year":"2017","unstructured":"Xue M, Chen X, Guo ZJ, Liu XQ, Bi YP, Yin J, et al. L-carnitine attenuates cardiac dysfunction by ischemic insults through Akt signaling pathway. Toxicol Sci. 2017;160:341\u201350.","journal-title":"Toxicol Sci"},{"key":"7088_CR224","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/BF00128244","volume":"5","author":"R Ferrari","year":"1991","unstructured":"Ferrari R, Ceconi C, Cargnoni A, Pasini E, Boffa GM, Curello S, et al. The effect of Propionyl-L-carnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria. Cardiovasc Drugs Ther. 1991;5:57\u201366.","journal-title":"Cardiovasc Drugs Ther"},{"key":"7088_CR225","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1161\/01.RES.0000138303.76488.fe","volume":"95","author":"A Tsang","year":"2004","unstructured":"Tsang A, Hausenloy DJ, Mocanu MM, Yellon DM. Postconditioning: a form of \u201cmodified reperfusion\u201d protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res. 2004;95:230\u20132.","journal-title":"Circ Res"},{"key":"7088_CR226","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cardiores.2006.01.024","volume":"70","author":"Z-Q Zhao","year":"2006","unstructured":"Zhao Z-Q, Vinten-Johansen J. Postconditioning: reduction of reperfusion-induced injury. Cardiovasc Res. 2006;70:200\u201311.","journal-title":"Cardiovasc Res"},{"key":"7088_CR227","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1161\/CIRCRESAHA.116.305348","volume":"116","author":"G Heusch","year":"2015","unstructured":"Heusch G. Molecular basis of cardioprotection signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res. 2015;116:674\u201399.","journal-title":"Circ Res"},{"key":"7088_CR228","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1161\/CIRCULATIONAHA.105.558122","volume":"112","author":"P Staat","year":"2005","unstructured":"Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L\u2019Huillier I, et al. Postconditioning the human heart. Circulation. 2005;112:2143\u20138.","journal-title":"Circulation"},{"key":"7088_CR229","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2015.223","author":"DC Hess","year":"2015","unstructured":"Hess DC, Blauenfeldt RA, Andersen G, Hougaard KD, Hoda MN, Ding Y, et al. Remote ischaemic conditioning-a new paradigm of self-protection in the brain. Nat Rev Neurol. 2015. https:\/\/doi.org\/10.1038\/nrneurol.2015.223.","journal-title":"Nat Rev Neurol"},{"key":"7088_CR230","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04786-y","author":"S Li","year":"2024","unstructured":"Li S, Xing X, Wang L, Xu J, Ren C, Li Y, et al. Remote ischemic conditioning reduces adverse events in patients with acute ischemic stroke complicating acute myocardial infarction: a randomized controlled trial. Crit Care. 2024. https:\/\/doi.org\/10.1186\/s13054-023-04786-y.","journal-title":"Crit Care"},{"key":"7088_CR231","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0140-6736(09)62001-8","volume":"375","author":"HE Botker","year":"2010","unstructured":"Botker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ, et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet. 2010;375:727\u201334.","journal-title":"Lancet"},{"key":"7088_CR232","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jcin.2014.05.015","volume":"8","author":"SK White","year":"2015","unstructured":"White SK, Frohlich GM, Sado DM, Maestrini V, Fontana M, Treibel TA, et al. Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction. Jacc-Cardiovasc Interv. 2015;8:178\u201388.","journal-title":"Jacc-Cardiovasc Interv"},{"key":"7088_CR233","first-page":"E161","volume":"115","author":"DJ Hausenloy","year":"2019","unstructured":"Hausenloy DJ, Botker HE. Why did remote ischaemic conditioning not improve clinical outcomes in acute myocardial infarction in the CONDI-2\/ERIC-PPCI trial? Cardiovasc Res. 2019;115:E161\u20133.","journal-title":"Cardiovasc Res"},{"key":"7088_CR234","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-021-00856-w","author":"TR Lassen","year":"2021","unstructured":"Lassen TR, Just J, Hjortbak MV, Jespersen NR, Stenz KT, Gu T, et al. Cardioprotection by remote ischemic conditioning is transferable by plasma and mediated by extracellular vesicles. Basic Res Cardiol. 2021. https:\/\/doi.org\/10.1007\/s00395-021-00856-w.","journal-title":"Basic Res Cardiol"},{"key":"7088_CR235","doi-asserted-by":"publisher","first-page":"11064","DOI":"10.3390\/ijms222011064","volume":"22","author":"B Bodi","year":"2021","unstructured":"Bodi B, Pilz PM, Martha L, Lang M, Hamza O, Fagyas M, et al. Alterations in ACE and ACE2 activities and cardiomyocyte signaling underlie improved myocardial function in a rat model of repeated remote ischemic conditioning. Int J Mol Sci. 2021;22:11064.","journal-title":"Int J Mol Sci"},{"key":"7088_CR236","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e29160","author":"Y Peng","year":"2024","unstructured":"Peng Y, Guo M, Luo M, Lv D, Liao K, Luo S, et al. Dapagliflozin ameliorates myocardial infarction injury through AMPK\u03b1-dependent regulation of oxidative stress and apoptosis. Heliyon. 2024. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29160.","journal-title":"Heliyon"},{"key":"7088_CR237","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.brainres.2006.03.114","volume":"1093","author":"K Chu","year":"2006","unstructured":"Chu K, Lee ST, Koo JS, Jung KH, Kim EH, Sinn DI, et al. Peroxisome proliferator-activated receptor-\u03b3-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia. Brain Res. 2006;1093:208\u201318.","journal-title":"Brain Res"},{"key":"7088_CR238","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-12-154","author":"DJ Hausenloy","year":"2013","unstructured":"Hausenloy DJ, Whittington HJ, Wynne AM, Begum SS, Theodorou L, Riksen N, et al. Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner. Cardiovasc Diabetol. 2013. https:\/\/doi.org\/10.1186\/1475-2840-12-154.","journal-title":"Cardiovasc Diabetol"},{"key":"7088_CR239","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/sj.bjp.0705775","volume":"142","author":"M Yamawaki","year":"2004","unstructured":"Yamawaki M, Sasaki N, Shimoyama M, Miake J, Ogino K, Igawa O, et al. Protective effect of edaravone against hypoxia-reoxygenation injury in rabbit cardiomyocytes. Br J Pharmacol. 2004;142:618\u201326.","journal-title":"Br J Pharmacol"},{"key":"7088_CR240","doi-asserted-by":"publisher","first-page":"13909","DOI":"10.3390\/ijms140713909","volume":"14","author":"K Kikuchi","year":"2013","unstructured":"Kikuchi K, Tancharoen S, Takeshige N, Yoshitomi M, Morioka M, Murai Y, et al. The efficacy of edaravone (Radicut), a free radical scavenger, for cardiovascular disease. Int J Mol Sci. 2013;14:13909\u201330.","journal-title":"Int J Mol Sci"},{"key":"7088_CR241","doi-asserted-by":"publisher","first-page":"1241065","DOI":"10.1155\/2020\/1241065","volume":"2020","author":"ZJ Mao","year":"2020","unstructured":"Mao ZJ, Lin H, Xiao FY, Huang ZQ, Chen YH. Melatonin against myocardial ischemia-reperfusion injury: a meta-analysis and mechanism insight from animal studies. Oxidative Med Cell Longev. 2020;2020:1241065.","journal-title":"Oxidative Med Cell Longev"},{"key":"7088_CR242","doi-asserted-by":"publisher","first-page":"41337","DOI":"10.1038\/srep41337","volume":"7","author":"LM Yu","year":"2017","unstructured":"Yu LM, Gong B, Duan WX, Fan CX, Zhang J, Li Z, et al. Melatonin ameliorates myocardial ischemia\/reperfusion injury in type 1 diabetic rats by preserving mitochondrial function: role of AMPK-PGC-1\u03b1-SIRT3 signaling. Sci Rep. 2017;7:41337.","journal-title":"Sci Rep"},{"key":"7088_CR243","doi-asserted-by":"publisher","first-page":"34793","DOI":"10.1074\/jbc.M202191200","volume":"277","author":"SJ Clarke","year":"2002","unstructured":"Clarke SJ, McStay GP, Halestrap AP. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A. J Biol Chem. 2002;277:34793\u20139.","journal-title":"J Biol Chem"},{"key":"7088_CR244","doi-asserted-by":"publisher","DOI":"10.1007\/s11655-015-2433-6","author":"Y-H Li","year":"2016","unstructured":"Li Y-H, Li Y-Y, Fan G-W, Yu J-H, Duan Z-Z, Wang L-Y, et al. Cardioprotection of ginsenoside Rb1 against ischemia\/reperfusion injury is associated with mitochondrial permeability transition pore opening inhibition. Chin J Integr Med. 2016. https:\/\/doi.org\/10.1007\/s11655-015-2433-6.","journal-title":"Chin J Integr Med"},{"key":"7088_CR245","first-page":"1065","volume":"11","author":"SS Yang","year":"2015","unstructured":"Yang SS, Li H, Tang L, Ge GH, Ma JW, Qiao ZY, et al. Apelin-13 protects the heart against ischemia-reperfusion injury through the RISK-GSK-3\u03b2-mPTP pathway. Arch Med Sci. 2015;11:1065\u201373.","journal-title":"Arch Med Sci"},{"key":"7088_CR246","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11655-016-2747-z","volume":"25","author":"XL Li","year":"2019","unstructured":"Li XL, Fan JP, Liu JX, Liang LN. Salvianolic acid A protects neonatal cardiomyocytes against hypoxia\/reoxygenation-induced injury by preserving mitochondrial function and activating Akt\/GSK-3 signals. Chin J Integr Med. 2019;25:23\u201330.","journal-title":"Chin J Integr Med"},{"key":"7088_CR247","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/cbin.11329","volume":"44","author":"CN Zi","year":"2020","unstructured":"Zi CN, Zhang CL, Yang YL, Ma J. Penehyclidine hydrochloride protects against anoxia\/reoxygenation injury in cardiomyocytes through ATP-sensitive potassium channels, and the Akt\/GSK-3\u03b2 and Akt\/mTOR signaling pathways. Cell Biol Int. 2020;44:1353\u201362.","journal-title":"Cell Biol Int"},{"key":"7088_CR248","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1748-1716.2010.02221.x","volume":"201","author":"D Johansen","year":"2011","unstructured":"Johansen D, Sanden E, Hagve M, Chu X, Sundset R, Ytrehus K. Heptanol triggers cardioprotection via mitochondrial mechanisms and mitochondrial potassium channel opening in rat hearts. Acta Physiol. 2011;201:435\u201344.","journal-title":"Acta Physiol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07088-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07088-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07088-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:04:51Z","timestamp":1761087891000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07088-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":248,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7088"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07088-9","relation":{"references":[{"id-type":"doi","id":"10.1042\/BSR20221212","asserted-by":"subject"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"8 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1140"}}